Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies-Reference-Cited by-同舟云学术

Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies

Published:2022-12 Issue:12 Volume:3 Page:100850
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Bruel Timothée,Stéfic Karl,Nguyen Yann,Toniutti Donatella,Staropoli Isabelle,Porrot Françoise,Guivel-Benhassine Florence,Bolland William-Henry,Planas Delphine,Hadjadj Jérôme,Handala Lynda,Planchais Cyril,Prot Matthieu,Simon-Lorière Etienne,André Emmanuel,Baele Guy,Cuypers Lize,Mouthon Luc,Mouquet Hugo,Buchrieser Julian,Sève Aymeric,Prazuck Thierry,Maes Piet,Terrier Benjamin,Hocqueloux Laurent,Schwartz Olivier

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference62 articles.

1. Emergence of SARS-CoV-2 omicron lineages BA.4 and BA.5 in South Africa;Tegally;Nat. Med.,2022

2. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa;Viana;Nature,2022

3. Imprinted SARS-CoV-2 humoral immunity induces converging Omicron RBD evolution;Cao;bioRxiv,2022

4. Antibody evasion properties of SARS-CoV-2 Omicron sublineages;Iketani;Nature,2022

5. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies;VanBlargan;Nat. Med.,2022

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement;Immunological Reviews;2024-09-13

2. Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial;Journal of Antimicrobial Chemotherapy;2024-09-05

3. Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study;Vaccines;2024-07-17

4. Editorial: Therapeutic management of COVID-19 in immunocompromised patients and interaction with the immune response: from preventive to curative strategies;Frontiers in Immunology;2024-07-16

5. Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era;International Journal of Infectious Diseases;2024-07